2024 Annual Meeting | C33 - Behavioral Neurology

Date Sunday 04/14/24

Time 07:00 AM - 09:00 AM MDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Roy H. Hamilton, MD, MS, FANA, F�鶹��ýӳ��

Topic(s) Aging, Dementia, and Behavioral Neurology

Learning Objectives Participants should be able to recognize recent research advances in the use of noninvasive neuromodulation techniques to study and treat aphasia, comprehend the important role of the cerebellum in the modulation and control of cognition, and identify the ways in which discoveries in visual neuroscience translate to advances in the clinical care of persons with neurodegenerative disorders

CME Available 2.00 CME credits

Core Competencies Medical Knowledge

Program Level Intermediate

Program Tracks Brain Health

Recommended Audience Fellow, General Neurologist, Specialist Neurologist, Medical Student

Teaching Styles Didactic

Event Timeline
07:00 AM - 07:30 AM MDT	Speaker	Neuromodulation in the Treatment of Aphasia Roy H. Hamilton, MD, MS, FANA, F�鶹��ýӳ��
07:30 AM - 07:40 AM MDT	Q&A	Questions & Answers Roy H. Hamilton, MD, MS, FANA, F�鶹��ýӳ��
07:40 AM - 08:10 AM MDT	Speaker	The Cognitive Cerebellum Chi-Ying (Roy) Lin, MD, F�鶹��ýӳ��
08:10 AM - 08:20 AM MDT	Q&A	Questions and Answers Chi-Ying (Roy) Lin, MD, F�鶹��ýӳ��
08:20 AM - 08:50 AM MDT	Speaker	Vision, Cognition, and Neurodegeneration Victoria S. Pelak, MD, F�鶹��ýӳ��
08:50 AM - 09:00 AM MDT	Q&A	Questions & Answers Victoria S. Pelak, MD, F�鶹��ýӳ��

Faculty Disclosures
Roy H. Hamilton, MD, MS, FANA, F�鶹��ýӳ��	Dr. Hamilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Highland Instruments. Dr. Hamilton has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognito Therapeutics. Dr. Hamilton has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for McKnight Brain Research Foundation. The institution of Dr. Hamilton has received research support from NIH. The institution of Dr. Hamilton has received research support from Department of Defense. The institution of Dr. Hamilton has received research support from Chan Zuckerberg Initiative.
Chi-Ying (Roy) Lin, MD, F�鶹��ýӳ��	Dr. Lin has received research support from Texas Alzheimer's Research and Care Consortium (TARCC). Dr. Lin has received research support from CurePSP. Dr. Lin has received research support from Mike Hogg Fund. Dr. Lin has received research support from The Michael J. Fox Foundation Parkinson's Progression Markers Initiative (PPMI). Dr. Lin has a non-compensated relationship as a Secretary with Broadway for Ataxia Foundation (a 501 (c) (3) non-profit organization) that is relevant to �鶹��ýӳ�� interests or activities.
Victoria S. Pelak, MD, F�鶹��ýӳ��	Dr. Pelak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Pelak has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for North American Neuro-ophthalmology Society. Dr. Pelak has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law Firms. The institution of Dr. Pelak has received research support from Biogen. Dr. Pelak has received publishing royalties from a publication relating to health care.